The drug manufacturer offers savings resources for Eliquis with a $10 Co-pay Card and a Free Trial Offer Card. For more information and to find out if you’re eligible for support, call 855-354 ...

Apixaban is a generic oral tablet that’s prescribed for certain types of blood clots. It’s available as the brand-name drug Eliquis. The cost of apixaban, with and without insurance, can ...

Update, March 1, 5 PM: Ramsay Baghadi of the RPM Report says that the Cardiorenal committee will take up the apixaban NDA on Mary 22 and the rivaroxaban supplemental NDA for the ACS indication on ...

New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were Uncommon Results ...

ELIQUIS ® (apixaban) Meets Primary and Key Secondary Endpoints in Phase 3 ARISTOTLE Study. Detailed results to be presented at European Society of Cardiology Congress 2011.

Apixaban oral tablet is available as a brand-name drug. It doesn’t have a generic version. Brand name: Eliquis. Apixaban only comes as a tablet you take by mouth. Apixaban is used to treat and ...

In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure ...

Apixaban is currently the most prescribed oral anticoagulant in the general population ... Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years ...

ELIQUIS ® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE ...

Apixaban comes in a brand-name version called Eliquis. To find out how the costs of Eliquis and apixaban compare, talk with your doctor, pharmacist, or insurance provider.

New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were Uncommon Results ...

Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person ... was also associated with ...